The Clorox Company (NYSE:CLX – Free Report) – Investment analysts at Zacks Research boosted their Q4 2026 earnings per share (EPS) estimates for Clorox in a research report issued to clients and investors on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.18 for the quarter, up from their prior estimate of $1.90. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share.
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 EPS.
Read Our Latest Research Report on Clorox
Clorox Trading Up 1.2 %
NYSE:CLX opened at $152.93 on Thursday. The business’s 50-day moving average is $158.11 and its two-hundred day moving average is $159.68. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market capitalization of $18.84 billion, a PE ratio of 41.78, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42.
Institutional Trading of Clorox
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Insight Folios Inc increased its holdings in Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after buying an additional 63 shares during the last quarter. Integral Investment Advisors Inc. increased its holdings in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after buying an additional 67 shares during the last quarter. HCR Wealth Advisors increased its holdings in Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC increased its holdings in Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after buying an additional 77 shares during the last quarter. Finally, Empower Advisory Group LLC increased its holdings in Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares during the last quarter. 78.53% of the stock is owned by institutional investors.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Short Selling: How to Short a Stock
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Start Investing in Real Estate
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.